SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001654954-20-010271
Filing Date
2020-09-21
Accepted
2020-09-21 09:15:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 424(B)3 azrx424b3.htm 424B3 719675
2 IMAGE azurrx_logo000.jpg GRAPHIC 5272
  Complete submission text file 0001654954-20-010271.txt   728168
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-240129 | Film No.: 201185324
SIC: 2834 Pharmaceutical Preparations